<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37393341</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1478-6362</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Arthritis research &amp; therapy</Title><ISOAbbreviation>Arthritis Res Ther</ISOAbbreviation></Journal><ArticleTitle>Renal interferon-inducible protein 16 expression is associated with disease activity and prognosis in lupus nephritis.</ArticleTitle><Pagination><StartPage>112</StartPage><MedlinePgn>112</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">112</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13075-023-03094-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lupus nephritis (LN) is one of the most severe complications of systemic lupus erythematosus (SLE). However, the current management of LN remains unsatisfactory due to sneaky symptoms during early stages and lack of reliable predictors of disease progression.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Bioinformatics and machine learning algorithms were initially used to explore the potential biomarkers for LN development. Identified biomarker expression was evaluated by immunohistochemistry (IHC) and multiplex immunofluorescence (IF) in 104 LN patients, 12 diabetic kidney disease (DKD) patients, 12 minimal change disease (MCD) patients, 12 IgA nephropathy (IgAN) patients and 14 normal controls (NC). The association of biomarker expression with clinicopathologic indices and prognosis was analyzed. Gene Set Enrichment Analysis (GSEA) and Gene Set Variation Analysis (GSVA) were utilized to explore potential mechanisms.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Interferon-inducible protein 16 (IFI16) was identified as a potential biomarker for LN. IFI16 was highly expressed in the kidneys of LN patients compared to those with MCD, DKD, IgAN or NC. IFI16 co-localized with certain renal and inflammatory cells. Glomerular IFI16 expression was correlated with pathological activity indices of LN, while tubulointerstitial IFI16 expression was correlated with pathological chronicity indices. Renal IFI16 expression was positively associated with systemic lupus erythematosus disease activity index (SLEDAI) and serum creatinine while negatively related to baseline eGFR and serum complement C3. Additionally, higher IFI16 expression was closely related to poorer prognosis of LN patients. GSEA and GSVA suggested that IFI16 expression was involved in adaptive immune-related processes of LN.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Renal IFI16 expression is a potential biomarker for disease activity and clinical prognosis in LN patients. Renal IFI16 levels may be used to shed light on predicting the renal response and develop precise therapy for LN.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xueyao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Shaojie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jinyu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Renal Pathology, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Fuzhe</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lihong</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pathology, Basic Medical College of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jiahui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Luyu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Huanfa</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Central Laboratory, The First Hospital of Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wu</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Hospital of Jilin University, Changchun, China. wu_hao@jlu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xu</LastName><ForeName>Zhonggao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Nephrology, The First Hospital of Jilin University, Changchun, China. zhonggao@jlu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Arthritis Res Ther</MedlineTA><NlmUniqueID>101154438</NlmUniqueID><ISSNLinking>1478-6354</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bioinformatics</Keyword><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Clinicopathologic significance</Keyword><Keyword MajorTopicYN="N">Interferon-inducible protein 16</Keyword><Keyword MajorTopicYN="N">Lupus nephritis</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>2</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>1</Day><Hour>23</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37393341</ArticleId><ArticleId IdType="pmc">PMC10314472</ArticleId><ArticleId IdType="doi">10.1186/s13075-023-03094-8</ArticleId><ArticleId IdType="pii">10.1186/s13075-023-03094-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yu F, Haas M, Glassock R, Zhao MH. Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol. 2017;13(8):483&#x2013;495. doi: 10.1038/nrneph.2017.85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2017.85</ArticleId><ArticleId IdType="pubmed">28669995</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Zhen Y, Ma Z, Li H, Yu J, Xu Z-G, et al. Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus. Sci Transl Med. 2016;8(331):331ra40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4895207</ArticleId><ArticleId IdType="pubmed">27009269</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Lee G, Liu X, Pascoe EM, Badve SV, Boudville NC, et al. Long-term outcomes of end-stage kidney disease for patients with lupus nephritis. Kidney Int. 2016;89(6):1337&#x2013;1345. doi: 10.1016/j.kint.2016.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2016.02.014</ArticleId><ArticleId IdType="pubmed">27165824</ArticleId></ArticleIdList></Reference><Reference><Citation>Parodis I, Tamirou F, Houssiau FA. Prediction of prognosis and renal outcome in lupus nephritis. Lupus Sci Med. 2020;7(1):e000389. doi: 10.1136/lupus-2020-000389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2020-000389</ArticleId><ArticleId IdType="pmc">PMC7046967</ArticleId><ArticleId IdType="pubmed">32153796</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, et al. Revision of the international society of nephrology/renal pathology society classification for lupus nephritis: Clarification of definitions, and modified national institutes of health activity and chronicity indices. Kidney Int. 2018;93(4):789&#x2013;796. doi: 10.1016/j.kint.2017.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2017.11.023</ArticleId><ArticleId IdType="pubmed">29459092</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin HA, 3rd, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med. 1983;75(3):382&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">6351607</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt JF, Rubin JM, Ellis JH. Lupus nephritis: predictive value of conventional and Doppler US and comparison with serologic and biopsy parameters. Radiology. 1997;203(1):82&#x2013;86. doi: 10.1148/radiology.203.1.9122420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiology.203.1.9122420</ArticleId><ArticleId IdType="pubmed">9122420</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz MM, Bernstein J, Hill GS, Holley K, Phillips EA. Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group. Kidney Int. 1989;36(5):891&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">2615196</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong T, Lv XS, Wu GJ, Guo YX, Liu C, Hou FX, et al. Single-cell sequencing analysis and multiple machine learning methods identified G0S2 and HPSE as novel biomarkers for abdominal aortic aneurysm. Front Immunol. 2022;13:907309. doi: 10.3389/fimmu.2022.907309.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.907309</ArticleId><ArticleId IdType="pmc">PMC9234288</ArticleId><ArticleId IdType="pubmed">35769488</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu S, Cheng Y, Wang X, Huang J, Su S, Wu H, et al. Identification of diagnostic gene biomarkers and immune infiltration in patients with diabetic kidney disease using machine learning strategies and bioinformatic analysis. Front Med (Lausanne) 2022;9:918657. doi: 10.3389/fmed.2022.918657.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.918657</ArticleId><ArticleId IdType="pmc">PMC9556813</ArticleId><ArticleId IdType="pubmed">36250071</ArticleId></ArticleIdList></Reference><Reference><Citation>Gariglio M, Mondini M, De Andrea M, Landolfo S. The multifaceted interferon-inducible p200 family proteins: from cell biology to human pathology. J Interferon Cytokine Res. 2011;31(1):159&#x2013;172. doi: 10.1089/jir.2010.0106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2010.0106</ArticleId><ArticleId IdType="pubmed">21198352</ArticleId></ArticleIdList></Reference><Reference><Citation>Song LL, Alimirah F, Panchanathan R, Xin H, Choubey D. Expression of an IFN-inducible cellular senescence gene, IFI16, is up-regulated by p53. Mol Cancer Res. 2008;6(11):1732&#x2013;1741. doi: 10.1158/1541-7786.MCR-08-0208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1541-7786.MCR-08-0208</ArticleId><ArticleId IdType="pubmed">18974396</ArticleId></ArticleIdList></Reference><Reference><Citation>Bawadekar M, De Andrea M, Lo Cigno I, Baldanzi G, Caneparo V, Graziani A, et al. The extracellular IFI16 protein propagates inflammation in endothelial cells via p38 MAPK and NF-&#x3ba;B p65 activation. J Interferon Cytokine Res. 2015;35(6):441&#x2013;453. doi: 10.1089/jir.2014.0168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2014.0168</ArticleId><ArticleId IdType="pmc">PMC4490711</ArticleId><ArticleId IdType="pubmed">25715050</ArticleId></ArticleIdList></Reference><Reference><Citation>Asefa B, Klarmann KD, Copeland NG, Gilbert DJ, Jenkins NA, Keller JR. The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation. Blood Cells Mol Dis. 2004;32(1):155&#x2013;167. doi: 10.1016/j.bcmd.2003.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcmd.2003.10.002</ArticleId><ArticleId IdType="pubmed">14757431</ArticleId></ArticleIdList></Reference><Reference><Citation>Caneparo V, Landolfo S, Gariglio M, De Andrea M. The absent in melanoma 2-Like Receptor IFN-inducible protein 16 as an inflammasome regulator in systemic lupus erythematosus: The dark side of sensing microbes. Front Immunol. 2018;9:1180. doi: 10.3389/fimmu.2018.01180.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01180</ArticleId><ArticleId IdType="pmc">PMC5985366</ArticleId><ArticleId IdType="pubmed">29892303</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell'Oste V, Gatti D, Giorgio AG, Gariglio M, Landolfo S, De Andrea M. The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response. New Microbiol. 2015;38(1):5&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">25742143</ArticleId></ArticleIdList></Reference><Reference><Citation>Briard B, Place DE, Kanneganti TD. DNA sensing in the innate immune response. Physiol (Bethesda) 2020;35(2):112&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7276919</ArticleId><ArticleId IdType="pubmed">32027562</ArticleId></ArticleIdList></Reference><Reference><Citation>Caneparo V, Cena T, De Andrea M, Dell'oste V, Stratta P, Quaglia M, et al. Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus. Lupus. 2013;22(6):607&#x2013;613. doi: 10.1177/0961203313484978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203313484978</ArticleId><ArticleId IdType="pubmed">23612796</ArticleId></ArticleIdList></Reference><Reference><Citation>Alunno A, Caneparo V, Carubbi F, Bistoni O, Caterbi S, Bartoloni E, et al. Interferon gamma-inducible protein 16 in primary Sj&#xf6;gren's syndrome: A novel player in disease pathogenesis? Arthritis Res Ther. 2015;17(1):208. doi: 10.1186/s13075-015-0722-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-015-0722-2</ArticleId><ArticleId IdType="pmc">PMC4536589</ArticleId><ArticleId IdType="pubmed">26271464</ArticleId></ArticleIdList></Reference><Reference><Citation>Baer AN, Petri M, Sohn J, Rosen A, Casciola-Rosen L. Association of antibodies to interferon-inducible protein-16 with markers of more severe disease in primary Sj&#xf6;gren's syndrome. Arthritis Care Res (Hoboken) 2016;68(2):254&#x2013;260. doi: 10.1002/acr.22632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22632</ArticleId><ArticleId IdType="pmc">PMC4847427</ArticleId><ArticleId IdType="pubmed">26037655</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahan ZH, Shah AA, Vaidya D, Wigley FM, Rosen A, Casciola-Rosen L. Anti-interferon-inducible protein 16 antibodies associate with digital gangrene in patients with scleroderma. Arthritis Rheumatol. 2016;68(5):1262&#x2013;1271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4848112</ArticleId><ArticleId IdType="pubmed">26714268</ArticleId></ArticleIdList></Reference><Reference><Citation>Alunno A, Caneparo V, Bistoni O, Caterbi S, Terenzi R, Gariglio M, et al. Circulating interferon-inducible protein IFI16 correlates with clinical and serological features in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2016;68(4):440&#x2013;445. doi: 10.1002/acr.22695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22695</ArticleId><ArticleId IdType="pubmed">26316393</ArticleId></ArticleIdList></Reference><Reference><Citation>De Andrea M, De Santis M, Caneparo V, Generali E, Sirotti S, Isailovic N, et al. Serum IFI16 and anti-IFI16 antibodies in psoriatic arthritis. Clin Exp Immunol. 2020;199(1):88&#x2013;96. doi: 10.1111/cei.13376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13376</ArticleId><ArticleId IdType="pmc">PMC6904656</ArticleId><ArticleId IdType="pubmed">31571199</ArticleId></ArticleIdList></Reference><Reference><Citation>Gugliesi F, Bawadekar M, De Andrea M, Dell'Oste V, Caneparo V, Tincani A, et al. Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane binding. PLoS ONE. 2013;8(5):e63045. doi: 10.1371/journal.pone.0063045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0063045</ArticleId><ArticleId IdType="pmc">PMC3653904</ArticleId><ArticleId IdType="pubmed">23690979</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets&#x2013;update. Nucleic Acids Res. 2013;41(D1):991&#x2013;995. doi: 10.1093/nar/gks1193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks1193</ArticleId><ArticleId IdType="pmc">PMC3531084</ArticleId><ArticleId IdType="pubmed">23193258</ArticleId></ArticleIdList></Reference><Reference><Citation>Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882&#x2013;883. doi: 10.1093/bioinformatics/bts034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts034</ArticleId><ArticleId IdType="pmc">PMC3307112</ArticleId><ArticleId IdType="pubmed">22257669</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Zhou S, Li S, Jiang Y, Wan Y, Ma X, et al. Eleven genes associated with progression and prognosis of endometrial cancer (EC) identified by comprehensive bioinformatics analysis. Cancer Cell Int. 2019;19:136. doi: 10.1186/s12935-019-0859-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12935-019-0859-1</ArticleId><ArticleId IdType="pmc">PMC6528324</ArticleId><ArticleId IdType="pubmed">31139013</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu S, Zhou Y, Hu C, Xu Z, Hou J. Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy. BMC complementary medicine and therapies. 2022;22(1):210. doi: 10.1186/s12906-022-03662-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12906-022-03662-6</ArticleId><ArticleId IdType="pmc">PMC9356435</ArticleId><ArticleId IdType="pubmed">35932042</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2(3):100141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8454663</ArticleId><ArticleId IdType="pubmed">34557778</ArticleId></ArticleIdList></Reference><Reference><Citation>Toth R, Schiffmann H, Hube-Magg C, B&#xfc;scheck F, H&#xf6;flmayer D, Weidemann S, et al. Random forest-based modelling to detect biomarkers for prostate cancer progression. Clin Epigenetics. 2019;11(1):148. doi: 10.1186/s13148-019-0736-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-019-0736-8</ArticleId><ArticleId IdType="pmc">PMC6805338</ArticleId><ArticleId IdType="pubmed">31640781</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X, Li C, Zhang Y, Su B, Fan M, Wei H. Selecting feature subsets based on SVM-RFE and the overlapping ratio with applications in bioinformatics. Molecules. 2017;23(1):52. doi: 10.3390/molecules23010052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules23010052</ArticleId><ArticleId IdType="pmc">PMC5943966</ArticleId><ArticleId IdType="pubmed">29278382</ArticleId></ArticleIdList></Reference><Reference><Citation>Jerome F, Trevor H, Rob T. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2929880</ArticleId><ArticleId IdType="pubmed">20808728</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725. doi: 10.1002/art.1780400928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400928</ArticleId><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Corwin HL, Schwartz MM, Lewis EJ. The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol. 1988;8(2):85&#x2013;89. doi: 10.1159/000167563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000167563</ArticleId><ArticleId IdType="pubmed">3394725</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604&#x2013;612. doi: 10.7326/0003-4819-150-9-200905050-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-150-9-200905050-00006</ArticleId><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Zhang Q, Chen Z, Huang Z, Zhang L, Chen F. Novel insight into ferroptosis-related genes, molecular subtypes, and immune characteristics in intracranial aneurysms. Inflamm Res. 2022;71(10&#x2013;11):1347&#x2013;1364. doi: 10.1007/s00011-022-01633-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-022-01633-8</ArticleId><ArticleId IdType="pubmed">36057911</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7. doi: 10.1186/1471-2105-14-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-7</ArticleId><ArticleId IdType="pmc">PMC3618321</ArticleId><ArticleId IdType="pubmed">23323831</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawada JI, Takeuchi S, Imai H, Okumura T, Horiba K, Suzuki T, et al. Immune cell infiltration landscapes in pediatric acute myocarditis analyzed by CIBERSORT. J Cardiol. 2021;77(2):174&#x2013;178. doi: 10.1016/j.jjcc.2020.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jjcc.2020.08.004</ArticleId><ArticleId IdType="pubmed">32891480</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson A, Aranow C, Mackay M. Lupus nephritis: challenges and progress. Curr Opin Rheumatol. 2019;31(6):682&#x2013;688. doi: 10.1097/BOR.0000000000000642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000642</ArticleId><ArticleId IdType="pmc">PMC6812494</ArticleId><ArticleId IdType="pubmed">31389814</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson MJ, Elwood NJ, Johnstone RW, Trapani JA. The IFN-inducible nucleoprotein IFI 16 is expressed in cells of the monocyte lineage, but is rapidly and markedly down-regulated in other myeloid precursor populations. J Leukoc Biol. 1998;64(4):546&#x2013;554. doi: 10.1002/jlb.64.4.546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jlb.64.4.546</ArticleId><ArticleId IdType="pubmed">9766636</ArticleId></ArticleIdList></Reference><Reference><Citation>Gariglio M, Azzimonti B, Pagano M, Palestro G, De Andrea M, Valente G, et al. Immunohistochemical expression analysis of the human interferon-inducible gene IFI16, a member of the HIN200 family, not restricted to hematopoietic cells. J Interferon Cytokine Res. 2002;22(7):815&#x2013;821. doi: 10.1089/107999002320271413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/107999002320271413</ArticleId><ArticleId IdType="pubmed">12184920</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Clarke CJ, Somers GR, Cresswell KS, Loveland KA, Trapani JA, et al. Expression of IFI 16 in epithelial cells and lymphoid tissues. Histochem Cell Biol. 2003;119(1):45&#x2013;54. doi: 10.1007/s00418-002-0485-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00418-002-0485-0</ArticleId><ArticleId IdType="pubmed">12548405</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondini M, Vidali M, De Andrea M, Azzimonti B, Air&#xf2; P, D'Ambrosio R, et al. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16. Arthritis Rheum. 2006;54(12):3939&#x2013;3944. doi: 10.1002/art.22266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22266</ArticleId><ArticleId IdType="pubmed">17133607</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanhove W, Peeters PM, Staelens D, Schraenen A, Van der Goten J, Cleynen I, et al. Strong upregulation of AIM2 and IFI16 inflammasomes in the mucosa of patients with active inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(11):2673&#x2013;2682. doi: 10.1097/MIB.0000000000000535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MIB.0000000000000535</ArticleId><ArticleId IdType="pubmed">26313692</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke CJ, Hii LL, Bolden JE, Johnstone RW. Inducible activation of IFI 16 results in suppression of telomerase activity, growth suppression and induction of cellular senescence. J Cell Biochem. 2010;109(1):103&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">19885868</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao JC, Lam R, Brazda V, Duan S, Ravichandran M, Ma J, et al. Interferon-inducible protein 16: insight into the interaction with tumor suppressor p53. Structure. 2011;19(3):418&#x2013;429. doi: 10.1016/j.str.2010.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2010.12.015</ArticleId><ArticleId IdType="pmc">PMC3760383</ArticleId><ArticleId IdType="pubmed">21397192</ArticleId></ArticleIdList></Reference><Reference><Citation>Aparicio P, Alonso JM, Toribio ML, Gutierrez JC, Pezzi L, Mart&#xed;nez C. Differential growth requirements and effector functions of alpha/beta and gamma/delta human T cells. Immunol Rev. 1989;111:5&#x2013;33. doi: 10.1111/j.1600-065X.1989.tb00540.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.1989.tb00540.x</ArticleId><ArticleId IdType="pubmed">2697682</ArticleId></ArticleIdList></Reference><Reference><Citation>Kratofil RM, Kubes P, Deniset JF. Monocyte Conversion During Inflammation and Injury. Arterioscler Thromb Vasc Biol. 2017;37(1):35&#x2013;42. doi: 10.1161/ATVBAHA.116.308198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.116.308198</ArticleId><ArticleId IdType="pubmed">27765768</ArticleId></ArticleIdList></Reference><Reference><Citation>Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science. 2010;327(5966):656&#x2013;661. doi: 10.1126/science.1178331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1178331</ArticleId><ArticleId IdType="pmc">PMC2887389</ArticleId><ArticleId IdType="pubmed">20133564</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Windgassen D, Papoutsakis ET. Comparative analysis of transcriptional profiling of CD3+, CD4+ and CD8+ T cells identifies novel immune response players in T-cell activation. BMC Genomics. 2008;9:225. doi: 10.1186/1471-2164-9-225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-9-225</ArticleId><ArticleId IdType="pmc">PMC2396644</ArticleId><ArticleId IdType="pubmed">18485203</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>